PlexBio Co., Ltd. (TPEX:6572)
Taiwan
· Delayed Price · Currency is TWD 6.90
-0.03 (-0.43%)
Mar 10, 2026, 1:29 PM CST
PlexBio Company Description
PlexBio Co., Ltd. develops and manufactures in vitro diagnostic reagents for molecular biology and immunology projects.
It offers workflow navigation services; automated sample preparation kits; IntelliPlex platform that is designed for πCode technology with throughput sample-to-answer multiplexing assays; oncology assays, a portfolio for advanced molecular testing; and πCode coupling buffer sets.
PlexBio Co., Ltd. was founded in 2009 and is based in Taipei, Taiwan.
PlexBio Co., Ltd.
| Country | Taiwan |
| Founded | 2009 |
| Industry | Medical Devices |
| Sector | Healthcare |
| CEO | Ting Cao |
Contact Details
Address: No. 351, Yangguang Street Taipei, 11491 Taiwan | |
| Phone | 886 2 2627 5878 |
| Website | plexbio.com |
Stock Details
| Ticker Symbol | 6572 |
| Exchange | Taipei Exchange |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | TWD |
| ISIN Number | TW0006572001 |
| SIC Code | 2835 |
Key Executives
| Name | Position |
|---|---|
| Dr. Ting Cao Ph.D. | Chairman, President and Chief Executive Officer |
| Lipi Yeh | Chief Financial Officer |
| Jiahong Hong | Accounting Supervisor |
| Dr. Chin-Shiou Huang | Vice President and Chief Technology Officer |
| Huei Te Uwe | Senior Administration Manager |
| Honggo Chang | Project and Sales Manager |